Ipratropium bromide metered solution inhalation - Sheffield

Drug Profile

Ipratropium bromide metered solution inhalation - Sheffield

Alternative Names: Ipratropium bromide MSI; MSI-ipratropium bromide; SCH 1000 metered solution inhalation - Sheffield

Latest Information Update: 17 Jun 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Sheffield Pharmaceuticals
  • Class Antiasthmatics; Antibronchitics; Atropine derivatives; Bronchodilators; Small molecules
  • Mechanism of Action Muscarinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Chronic obstructive pulmonary disease

Most Recent Events

  • 17 Jun 2003 Sheffield Pharmaceuticals has filed for protection under Chapter 7 bankruptcy laws
  • 17 Jun 2003 Discontinued - Phase-II for Chronic obstructive pulmonary disease in Belgium (Inhalation)
  • 17 Jun 2003 Discontinued - Phase-II for Chronic obstructive pulmonary disease in USA (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top